Herbal Supplement Interactions: A Pharmacist’s Guide to Safer Use
Herbal supplements are often perceived as gentle, natural and compatible with prescription medicines. That assumption can create serious medication-safety risks. A product purchased from a pharmacy, health-food shop, supermarket or online marketplace may alter drug concentrations, increase adverse effects or make treatment less effective.
For Australian pharmacists, the challenge is complicated by the popularity of complementary medicines and the wide range of products available under the Therapeutic Goods Administration (TGA) framework. A careful conversation at the counter can uncover risks that a patient may never think to mention, particularly when several medicines, chronic conditions or multiple practitioners are involved.
Why Natural Products Need Clinical Scrutiny
“Natural” describes a source, not a safety profile. Herbal products contain biologically active chemicals that may affect liver enzymes, transport proteins, blood clotting, blood pressure, heart rhythm and the central nervous system. Their effects may be predictable in a standardised extract but much less consistent in a product with variable strength or several combined ingredients.
Some complementary medicines are listed on the Australian Register of Therapeutic Goods as AUST L products, while higher-risk or more thoroughly evaluated products may be registered as AUST R medicines. Listing does not mean a product is free from interactions, nor does it guarantee that every batch has the same clinical effect as a prescription medicine. Patients may also bring home products purchased during overseas travel or ordered from international websites.
Pharmacists should therefore treat herbal products as medicines during medication reconciliation. Tea, powder, capsule, gummy, tincture and concentrated liquid preparations can all be relevant. The form and dose matter, especially when a patient is taking a narrow-therapeutic-index medicine such as warfarin, digoxin, lithium, tacrolimus or phenytoin.
How Herbal Medicines Change Drug Effects
Pharmacokinetic interactions occur when a supplement changes absorption, metabolism or elimination. St John’s wort is the classic example. Its constituents can induce CYP3A4 and P-glycoprotein, reducing exposure to several medicines, including some oral contraceptives, anticoagulants, immunosuppressants, antiretrovirals and anticonvulsants. A patient may take it for low mood while unknowingly undermining another essential treatment.
Pharmacodynamic interactions happen when two substances produce overlapping effects. Ginkgo, garlic and concentrated turmeric products may increase bleeding risk when combined with anticoagulants, antiplatelet medicines or non-steroidal anti-inflammatory drugs. Sedating herbs such as valerian, passionflower and kava can compound the effects of alcohol, opioids, benzodiazepines and sleep medicines.
Interactions can begin after a product is started, but they may also appear after a dose is increased or a patient stops taking it. Enzyme induction may take time to develop and may persist after discontinuation. This makes a complete product history more useful than a simple question about whether the patient is “taking any medications”.
Supplements That Deserve Extra Attention
St John’s wort deserves particular caution in community pharmacy. It is marketed for mild mood symptoms, yet it has a broad interaction profile. It may reduce the reliability of hormonal contraception and affect antidepressants, potentially contributing to serotonin toxicity when combined with serotonergic medicines. Patients using it should receive specific advice before starting, stopping or switching therapy.
Kava has been associated with liver injury and is unsuitable for casual use in people with liver disease or those taking hepatotoxic medicines. Ashwagandha products have also raised concerns involving liver injury, thyroid effects and immune activity. Green tea extract may be tolerated as a beverage but can present a different risk when concentrated in weight-loss or bodybuilding products.
Products that influence coagulation deserve a careful review before surgery or dental procedures. Ginkgo, garlic, ginseng, dong quai and high-dose fish oil may be relevant, although the degree of risk varies by preparation and dose. Cranberry products are often discussed in relation to warfarin, but evidence is inconsistent; the safest approach is to assess the individual product, dose and international normalised ratio rather than rely on a blanket rule.
People with asthma, allergic rhinitis or a history of severe reactions may also respond to botanical ingredients, excipients or contaminated products. When a patient describes a possible supplement-related reaction, accessible allergy information can support broader education, while urgent symptoms such as facial swelling, wheeze, collapse or difficulty breathing require emergency care.
A Practical Interaction Comparison
The following examples are useful prompts rather than an exhaustive interaction database. Risk depends on the ingredient, extract ratio, dose, duration, patient characteristics and concurrent medicines. A pharmacist should verify important combinations through a current, reliable reference before advising a patient.
| Herbal product or category | Possible interaction | Medicines or patients requiring caution | Pharmacist action |
|---|---|---|---|
| St John’s wort | Enzyme induction; reduced drug exposure; serotonin-related effects | Oral contraceptives, antidepressants, anticoagulants, transplant medicines, anticonvulsants | Obtain the full medicine list and recommend medical review before use |
| Ginkgo, garlic, dong quai | Increased bleeding tendency | Warfarin, apixaban, rivaroxaban, aspirin, clopidogrel, planned surgery | Assess bleeding history and communicate with the prescriber |
| Kava | Sedation and possible liver injury | Alcohol, opioids, benzodiazepines, liver disease | Discourage unsupervised use and check for hepatic symptoms |
| Ashwagandha | Possible liver and thyroid effects; immune modulation | Thyroid disease, autoimmune illness, hepatotoxic medicines | Review indication, duration and symptoms; refer when appropriate |
| Valerian and passionflower | Additive sedation and impaired coordination | Sleep medicines, opioids, antihistamines, alcohol | Discuss driving, falls and combined sedative use |
| Concentrated green tea extract | Possible liver injury; altered drug exposure in some cases | Weight-loss products, liver disease, multiple medicines | Check dose, product quality and liver-related symptoms |
A patient taking several products may face cumulative risk even when each individual item appears modest. For example, a person using ginkgo, an over-the-counter anti-inflammatory and apixaban has a different risk profile from someone taking ginkgo alone. The same principle applies to sedation, blood pressure lowering and effects on blood glucose.
The Questions That Reveal Hidden Use
A non-judgemental approach improves disclosure. Patients may omit supplements because they believe they are irrelevant, because a prescriber did not ask, or because they use them intermittently. Asking “Which prescription, over-the-counter and complementary products do you use, including teas and powders?” is more productive than asking only about “medications”.
The pharmacist should record the brand, active ingredients, strength, dose, frequency, purpose, start date and source. A photograph of the label can help when the product is at home. It is also important to ask about recent changes, planned procedures, pregnancy or breastfeeding, allergies, liver or kidney disease and symptoms such as bruising, palpitations, excessive drowsiness or jaundice.
Patients may consult several healthcare professionals, including a GP, nurse, naturopath, specialist and pharmacist. Clear communication across that network reduces duplication and contradictory advice. A concise, evidence-based medication summary can be particularly valuable when care is shared between a suburban pharmacy in Melbourne, a regional clinic in Queensland or a hospital service in Perth.
Australian Considerations For Safer Counselling
Australian consumers commonly encounter complementary medicines in major pharmacy chains, independent pharmacies, health-food retailers and online stores. A TGA number on a package can help identify the product’s regulatory category, but it should not be presented as proof that the product is appropriate for a particular person or interaction-free. Patients should be encouraged to retain packaging and avoid decanting capsules into unlabelled containers.
Product quality is another concern. Imported supplements may contain undeclared prescription drugs, excessive doses or ingredients that differ from the Australian label. This matters for people who buy products through social media, overseas websites or informal community networks. Pharmacists can explain that “traditional use” claims do not replace an assessment of current medicines and health conditions.
Local habits also shape risk. Patients may combine supplements with popular wellness routines, fasting, gym products or herbal teas served at home. Older Australians may use multiple medicines for cardiovascular disease, diabetes and arthritis, while younger adults may combine mood products with hormonal contraception or stimulant-based pre-workout formulas. In Aboriginal and Torres Strait Islander communities, culturally safe conversations and respect for traditional healing practices are essential; pharmacists should avoid dismissing traditional knowledge while still checking for interactions and toxicology concerns.
Pharmacy teams can strengthen practice by using current Australian references, documenting advice and escalating suspected adverse reactions. The TGA accepts reports through its adverse event reporting pathways, and serious symptoms should be managed promptly rather than monitored informally. Professional education and a reflective clinical pharmacy perspective can also help pharmacists communicate uncertainty without creating unnecessary alarm.
Recommendations For Everyday Pharmacy Practice
A consistent process helps make supplement screening part of routine care rather than an occasional response to a problem. The following steps are suitable for dispensing, medication reviews, vaccination consultations and minor-ailment discussions:
- Ask specifically about herbal medicines, vitamins, teas, powders, gummies, sports products and traditional remedies.
- Record the exact brand, ingredients, dose, frequency, purpose and date started.
- Prioritise checks for anticoagulants, antidepressants, anticonvulsants, transplant medicines, diabetes treatments and narrow-therapeutic-index drugs.
- Review risks related to pregnancy, breastfeeding, surgery, liver disease, kidney disease and allergy history.
- Explain what symptoms require urgent attention, including unusual bleeding, severe sedation, jaundice, palpitations and breathing difficulty.
- Encourage patients to tell every prescriber and pharmacist about complementary medicines.
- Document the discussion and refer to the GP or specialist when treatment changes, monitoring or diagnostic assessment may be needed.
This approach supports shared decision-making. The objective is not to reject every herbal product, but to distinguish a reasonable, monitored choice from an unrecognised hazard. Some patients will choose to continue a supplement after receiving balanced information; the pharmacist’s role is to help them understand the possible consequences and arrange appropriate follow-up.
Turning Supplement Conversations Into Prevention
A short interaction check can prevent a hospital admission, contraceptive failure, withdrawal complication or avoidable adverse reaction. It can also uncover untreated depression, problematic self-medication, disordered eating or pressure from online health claims. When a patient is using St John’s wort for persistent low mood, for example, the conversation should include mental-health assessment and referral rather than focusing solely on enzyme interactions.
Communication should be specific and practical. “Do not take natural products” is unlikely to change behaviour. A better explanation might identify the relevant medicine, describe the suspected effect, state whether the supplement should be stopped or reviewed, and provide a clear escalation plan. Patients should understand when to contact the pharmacy, prescriber or emergency services.
Pharmacists are well placed to make hidden supplement use visible. By asking precise questions, checking credible sources and documenting shared decisions, they can protect treatment effectiveness while respecting patient autonomy. In Australia’s broad and rapidly changing complementary-medicine market, that routine vigilance is a central part of safe medication care.
Make herbal products part of every medication history, verify interactions before recommending or dispensing, and refer promptly when symptoms or high-risk medicines are involved. A careful pharmacist conversation may be the most important safeguard between a “natural” product and a preventable harm.